Search results for

This week’s North America Awards recognised the outstanding firms and individuals in IP work in the United States and Canada. In today’s blog we pick out some of the highlights

Simon Crompton explains the impact of three countries joining or clearing the last hurdles to join the international trade mark system

Case of the Year: Apple v Samsung

The IFI Claims US Top 50 ranking of patent recipients reveals IBM acquired the most patents ever of any company in a year. Asian companies account for more than half of the top 50

The latest article in our series by the MARQUES IP Outer Borders Team looks at the localism trend and its implications for brands. By Kate Swaine, Mary Jane Lemenchick, Laetitia Lagarde and Thomas Raab

The so-called trilogue, comprising representatives of the EU Council, Commission and Parliament, could decide today how to reform the Trade Marks Directive and CTM Regulation, and what to do with OHIM’s surplus

In Thailand, registrars seeking to solve the problem of a mistakenly registered trade mark may call upon the solution in section 61 of the Thai Trade Mark Act, which permits the Board of Trade Marks to re-examine such marks. Based on this section, the Board conducts re-examinations on distinctiveness, dissimilarity, and morality grounds only when an authorised person, limited to either an interested person or a registrar, files a cancellation petition to the Board citing section 61. In the view of many registrars, section 61 provides a means of effectively revisiting decisions; nevertheless, the registrars, having already given their approval, rarely seek to use this solution. Recently, however, the Board rendered a decision in favour of the registrar's use of section 61 by withdrawing a registered trade mark which had been registered for more than five years.

With new legislation proposed around the world, there is increased focus on trade secrets protection. All the more reason to get your corporate policies in order now, argue Robert Williams, Warren Wayne and Toby Bond

Ben Brigou and Jaap Mannaerts of NLO examine the different incentives the EU offers in order to encourage pharmaceutical innovation, including SPCs, regulatory measures and the Bolar exemption

Data provided to Managing IP by IFI Claims Patent Services reveals the law firms used the most for US utility patents granted in 2014, with Oblon leading the pack